Profil
Steen Kroyer is currently the Chairman at Maab International and Kroyer Consulting Ltd.
He was previously the Chief Executive Officer at Bionor Pharma ASA in 2013 and the Chief Executive Officer at Astrazeneca China Ltd.
He also served as a Director at Quiapeg Pharmaceuticals Holding AB from 2018 to 2022.
Postes actifs de Steen Kroyer
| Sociétés | Poste | Début |
|---|---|---|
| Maab International | Président | 01/07/2014 |
| Kroyer Consulting Ltd. | Président | 01/03/2014 |
Anciens postes connus de Steen Kroyer
| Sociétés | Poste | Fin |
|---|---|---|
| QUIAPEG PHARMACEUTICALS HOLDING AB | Président | 09/06/2022 |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | President | - |
| Astrazeneca China Ltd. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
| Astrazeneca China Ltd. | |
| Maab International | |
| Kroyer Consulting Ltd. |